Demi Soulet, PA-C

Demi Soulet practices at Advanced Dermatology and Cosmetic Surgery in Maitland, Florida.

Demi Soulet's NPI, 1558879767, was assigned on January 22, 2018.

Demi Soulet's primary practice is Advanced Dermatology and Cosmetic Surgery, at 151 Southhall Ln, Maitland, FL 32751 in Orange County. The practice phone is (407) 333-4200.

Demi Soulet's primary practice is Advanced Dermatology and Cosmetic Surgery in Maitland, Florida. The medical group on file is Advanced Dermatology and Cosmetic Surgery. Dmand AI also links Demi Soulet to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Demi Soulet practices. Vendor and product names are available with a free account.

Medical is Demi Soulet's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Demi Soulet has a license on file in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, head wound and itchy rashes among the conditions Demi Soulet treats.

CMS data shows 202 Medicare services from Demi Soulet across 6 procedure codes in 2024, for 93 Medicare patients. Medicare paid $6,532 for them. Every service was in an office.

CMS counts 93 Medicare patients who saw Demi Soulet in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Demi Soulet's median patient age at 56, with 64% women.

In 2024, Demi Soulet wrote 963 Medicare Part D claims for 322 patients. 90% of them were for generic drugs. CMS names the drug for 813 of them, across 18 drugs with 11 or more claims each, at $156,500 in total drug cost.

Demi Soulet accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 336 general payments to Demi Soulet from 23 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 80% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,600.